Clinical Trials
Source: CCM
- Score: 8Orthopaedics, Muscle & Bone
BMS 246 - Systemic Lupus Erythematosus (SLE)
- Score: 7Immune System
Yale Lupus and Connective Tissue Disease Bio-Repository / Yale Rheumatology Bio-Repository
- Ages18 years and older
- GenderBoth
- Score: 6Skin/Dermatology, Immune System
Genome Research in African American Scleroderma Patients (GRASP Study)
- Ages18 years and older
- GenderBoth
- Score: 5Immune System
Characterization of SSc-ILD patients and linkage to clinical outcomes
- Ages18 years and older
- GenderBoth
- Score: 4
TROPICS
- Score: 3Skin/Dermatology, Orthopaedics, Muscle & Bone
The Scleroderma Patient-centered Intervention Network (SPIN)
- Ages18 years and older
- GenderBoth
- Score: 2Orthopaedics, Muscle & Bone
Phase III Study to Evaluate the Safety and Efficacy of Anifrolumab Compared with Placebo in Male and Female Participants 18 to 70 Years of Age Inclusive with Systemic Sclerosis
- Ages18 years - 70 years
- GenderBoth
- Score: 1Immune System
Pathogenic Wnt-beta catenin target genes in macrophages and fibrosis
- Score: 0COVID-19 Inpatient, COVID-19 Outpatient
Long Covid: Understanding Immune, Symptom, and Treatment Experiences Nationwide (LISTEN Study)
- Ages18 years and older
- GenderBoth